source
- Biotech deal activity picks up in Q2 2026, signaling recovery after summer slumpThe biotech sector experienced a sharp decline in confidence last summer, leading to a slowdown in financing and partnership activity. New data show that in the second quarter of 2026, dealmaking…
- House passes FDA Modernization Act 3.0 to push update of animal testing regulationsThe U.S. House approved the FDA Modernization Act 3.0, a bill aimed at modernizing preclinical testing rules. The legislation requires the FDA to revise regulations that still reference animal tes…